CannaMD

OCTOBER 29, 2020

On the contrary, after analyzing cross-sectional data from two population-based surveys including over 50,000 respondents, the American Journal of Epidemiology reports: The proportion of obese participants decreased with the frequency of cannabis use. Cannabis: 2. What’s scarier than a Halloween mask? Cannabis: 3. Shaking with fear!

Research and Development 92

Research and Development Blood Pressure Data Clinical Trials 92

Cannabis Law Report

MARCH 29, 2020

This “zero recall” standard, the team said, was attributed to the fact that their cannabis product standards with regard to food safety and health was high and involved documentation of over 100 pages. . among human subjects, legal knowledge of the laws outlined the Cannabis Act should be distributed to all participants ahead of time.

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

The Cannigma

AUGUST 31, 2021

The researchers stated that these knowledge gaps must be addressed and that “clinical trial data about how medical cannabis improves patient quality of life domains is desperately needed as this information can impact clinical decision-making.”. The survey also found that 89.5%

Education 101

Education Clinical Trials Medicine Policy 101

Cannabis Law Report

NOVEMBER 19, 2021

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. Advise executive members on new laws, existing laws, and legal rights and obligations that would impact functionality of the business.

Therapy 40

Therapy Compliance Compliance Clinical Trials 40

CannaMD

MARCH 8, 2020

Few randomized clinical trials have been conducted or are planned to explore the effects of marijuana on cardiovascular risk. Screening and testing for use of marijuana are encouraged in clinical settings, especially in the care of young patients presenting with cardiovascular disease.

Patients 79

Patients Marijuana Research and Development Clinical Trials 79

The Joint Blog

JANUARY 12, 2020

Passage of the 2018 Farm Bill, which eased federal legal restrictions on hemp cultivation and transport, unleashed a stampede of companies rushing products to the market in an absence of regulations ensuring safety, quality and effectiveness. “The Still, scientific documentation of CBD’s safety and efficacy is nearly nonexistent.

Pets 36

Pets CBD Clinical Trials Research and Development 36

Cannabis Law Report

JULY 9, 2022

“I found that Johns Hopkins and other major research universities were doing clinical studies on psilocybin and treatment-resistant depression.”. There’s a growing body of studies documenting the beneficial effects of psilocybin on depression and mood disorders, with new data emerging all the time.

Microdosing 52

Microdosing Wellness and Beauty Research and Development Clinical Trials 52

Cannabis Law Report

JANUARY 20, 2022

ELE-Psilo program expected to enter clinical trials in Q2 2022 and to target the pressing need for rapid-acting antidepressants compatible with existing healthcare infrastructure and insurance. Canaccord Genuity LLC is serving as financial advisor and Latham & Watkins LLP is serving as legal advisor to Eleusis.

Therapy 52

Therapy Research and Development Business Access 52

TheAnswerPage

JANUARY 11, 2022

In November 1996, California became the first state to legalize the use of medical marijuana, and now 25 years later, more than 70% of the US population resides in a state or territory with medical marijuana laws in place, and there are nearly 5.5 million medical marijuana patients nationwide. So, why did this educational gap develop?

Patients 98

Patients Education Marijuana Therapy 98

SpeedWeed

DECEMBER 28, 2018

My personal year in cannabis began on New Year’s Day, when I waited in line along with countless other Californians to buy some cannabis on the first day of legal adult-use sales. Or that Thailand is blazing a trail in Asia—where cannabis laws are often draconian and harshly enforced—by legalizing medical use ( yes! ).

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

Cannabis Law Report

JUNE 30, 2019

The House Committee on Veterans’ Affairs discussed legislation last week that would allow doctors at the US Department of Veterans Affairs (VA) to issue medical cannabis recommendations in states where it’s legal. Congress has asked vaporizer company JUUL for documents on any partnerships it may have with cannabis companies.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Andrew is a supporter of legalizing psychedelic drugs and has been vocal about his intentions if he were to assume a government office.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

JULY 24, 2019

New drugs may not be legally introduced or delivered for introduction into interstate commerce without prior approval from the FDA, as described in sections 301(d) and 505(a) of the FD&C Act, 21 U.S.C. FDA approves a new drug on the basis of scientific data and information demonstrating that the drug is safe and effective.

CBD 51

CBD Tincture Pets Chronic Pain 51

Cannabis Law Report

NOVEMBER 24, 2021

At the same time, the outlook on cannabis research data is largely positive. Firstly, we contextualise cannabis in terms of its historical usage, its legal status, and research relating to knowledge, attitudes, and usage. This article analyses media representations of medicinal cannabis in Australian medical publications. Bonini et al.

Research and Development 52

Research and Development Medicine Access Media 52